Current controversies in the initial post-surgical radioactive iodine therapy for thyroid cancer: a narrative review

“

This review was written due to current pressures to limit the dose of radioactive iodine, or forego radioactive iodine therapy completely, for certain patients in the initial post-surgical setting for thyroid cancer. It is out belief that the literature does not currently support a change from "standard" dosing and that doing so may in fact be harmful, with the overarching goal of therapy being to improve survival.

”